The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 achieves antitumor activity in PIK3CA-Mutant breast cancer brain metastases - Ippen, Franziska M. (Clinical cancer research, 2019)
Gesehen am 17.09.2019